Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1959 2
1960 2
1962 1
1965 6
1966 1
1967 10
1968 13
1969 26
1970 20
1971 56
1972 58
1973 82
1974 98
1975 115
1976 108
1977 144
1978 129
1979 119
1980 110
1981 113
1982 127
1983 127
1984 134
1985 145
1986 154
1987 111
1988 123
1989 110
1990 105
1991 147
1992 118
1993 135
1994 117
1995 125
1996 131
1997 110
1998 128
1999 124
2000 133
2001 146
2002 127
2003 127
2004 156
2005 160
2006 148
2007 168
2008 198
2009 204
2010 228
2011 244
2012 253
2013 274
2014 264
2015 284
2016 336
2017 401
2018 390
2019 387
2020 565
2021 492
2022 72
2023 27
2024 692
2025 689

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9,886 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy in Breast Cancer.
Dvir K, Giordano S, Leone JP. Dvir K, et al. Int J Mol Sci. 2024 Jul 9;25(14):7517. doi: 10.3390/ijms25147517. Int J Mol Sci. 2024. PMID: 39062758 Free PMC article. Review.
Towards targeting the breast cancer immune microenvironment.
Harris MA, Savas P, Virassamy B, O'Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R, Loi S. Harris MA, et al. Nat Rev Cancer. 2024 Aug;24(8):554-577. doi: 10.1038/s41568-024-00714-6. Epub 2024 Jul 5. Nat Rev Cancer. 2024. PMID: 38969810 Review.
Current and future immunotherapy for breast cancer.
Heater NK, Warrior S, Lu J. Heater NK, et al. J Hematol Oncol. 2024 Dec 25;17(1):131. doi: 10.1186/s13045-024-01649-z. J Hematol Oncol. 2024. PMID: 39722028 Free PMC article. Review.
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S; International TILs Working Group 2014. Salgado R, et al. Ann Oncol. 2015 Feb;26(2):259-71. doi: 10.1093/annonc/mdu450. Epub 2014 Sep 11. Ann Oncol. 2015. PMID: 25214542 Free PMC article.
Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis.
Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, Salgado R, Byrne DJ, Teo ZL, Dushyanthen S, Byrne A, Wein L, Luen SJ, Poliness C, Nightingale SS, Skandarajah AS, Gyorki DE, Thornton CM, Beavis PA, Fox SB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab); Darcy PK, Speed TP, Mackay LK, Neeson PJ, Loi S. Savas P, et al. Nat Med. 2018 Jul;24(7):986-993. doi: 10.1038/s41591-018-0078-7. Epub 2018 Jun 25. Nat Med. 2018. PMID: 29942092
Vaccine Therapies for Breast Cancer.
Burke EE, Kodumudi K, Ramamoorthi G, Czerniecki BJ. Burke EE, et al. Surg Oncol Clin N Am. 2019 Jul;28(3):353-367. doi: 10.1016/j.soc.2019.02.004. Epub 2019 Apr 5. Surg Oncol Clin N Am. 2019. PMID: 31079793 Review.
Starfysh integrates spatial transcriptomic and histologic data to reveal heterogeneous tumor-immune hubs.
He S, Jin Y, Nazaret A, Shi L, Chen X, Rampersaud S, Dhillon BS, Valdez I, Friend LE, Fan JL, Park CY, Mintz RL, Lao YH, Carrera D, Fang KW, Mehdi K, Rohde M, McFaline-Figueroa JL, Blei D, Leong KW, Rudensky AY, Plitas G, Azizi E. He S, et al. Nat Biotechnol. 2025 Feb;43(2):223-235. doi: 10.1038/s41587-024-02173-8. Epub 2024 Mar 21. Nat Biotechnol. 2025. PMID: 38514799 Free PMC article.
Immune Escape during Breast Tumor Progression.
Gil Del Alcazar CR, Alečković M, Polyak K. Gil Del Alcazar CR, et al. Cancer Immunol Res. 2020 Apr;8(4):422-427. doi: 10.1158/2326-6066.CIR-19-0786. Cancer Immunol Res. 2020. PMID: 32238387 Free PMC article. Review.
9,886 results